## Background: Hepatocellular carcinoma (hcc) is one of the most common human tumors in asia and africa. the molecular genetic changes involving both protooncogenes and tumor suppressor genes are known to be involved in hepatocarcinogenesis, but the roles of the known tumor suppressor genes in hepa
Analysis of loss of heterozygosity in murine hepatocellular tumors
β Scribed by Giacomo Manenti; Laura De Gregorio; Manuela Gariboldi; Tommaso A. Dragani; Marco A. Pierotti
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 788 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0899-1987
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Because allelotype analysis of tumors has been important in the identification of new tumor suppressor genes, here we studied loss of heterozygosity (LOH) in a wellβdefined animal experimental system. We analyzed spontaneous liver tumors from C3HHc Γ C57BL/61 (B6C3F1) mice and urethaneβinduced hepatocellular tumors from (C3H/He Γ Mus spretus) Γ C57BL/6JBy (HSB) interspecific mice. A total of 95 different genetic markers were tested: 13 in 24 B6C3F1 tumors, 76 in 58 HSB tumors, and six in both groups. Minisatellite fingerprinting analysis detected one case of LOH and less than 1% genomic rearrangements in polymorphic and nonpolymorphic bands, respectively. There were no changes at hepatocellular susceptibility loci or at markers homologous to loci frequently lost in human hepatocellular carcinomas. Therefore, our results suggest that LOH and genomic rearrangements are uncommon in mouse hepatocellular tumors. Β© 1995 WileyβLiss, Inc.
π SIMILAR VOLUMES
## I Wilms' tumor-specific loss of heterozygosity (LOH) for DNA markers located at chromosomes llp13, llp15, 16q, and l p has been reportedtooccur in a minorityofWiIms'tumors. We hypothesized that tumors classified by region of LOH would exhibit specific clinicopathologic patterns. We have therefo
We investigated 24 hepatocellular carcinomas in Japan to find loss of heterozygosity with 15 polymorphic DNA markers that detect allelic losses at specific chromosome loci. Loss of heterozygosity on chromosomes lOq, 17p and 22q was detected in 3 of 12 (26%), 9 of 21 (43%) and 5 of 15 (33%) informati
Deletion of 17p is the most frequent abnormality observed in central nervous system (CNS) primitive neuroectodermal tumors (PNETs), implicating the presence of a tumor suppressor gene which maps to 17p. The gene for pigment epitheliumderived factor (PEDF) has been cloned and mapped to 17p13. PEDF be